Rakebrandt Nikolas, Littringer Katharina, Joller Nicole
Institute of Experimental Immunology, University of Zürich, Switzerland.
Swiss Med Wkly. 2016 Aug 6;146:w14343. doi: 10.4414/smw.2016.14343. eCollection 2016.
Foxp3+ regulatory T cells (Tregs) maintain immune tolerance, prevent autoimmunity and modulate immune responses during infection and cancer. Recent studies have revealed considerable heterogeneity and plasticity within the Treg compartment, depending on the immunological context, which may result in Tregs losing their suppressive function in inflammatory environments. We review how dysfunctional Tregs contribute to disease pathogenesis in inflammatory conditions and how inappropriate regulatory responses may hamper protective immunity in the context of infection and cancer. We also discuss how Tregs might be targeted therapeutically to re-establish a proper balance between regulatory and effector responses in autoimmunity, infections, and cancer.
Foxp3+调节性T细胞(Tregs)维持免疫耐受,预防自身免疫,并在感染和癌症期间调节免疫反应。最近的研究表明,根据免疫背景,Treg细胞群内存在相当大的异质性和可塑性,这可能导致Tregs在炎症环境中丧失其抑制功能。我们综述了功能失调的Tregs如何在炎症条件下导致疾病发病机制,以及不适当的调节反应如何在感染和癌症背景下阻碍保护性免疫。我们还讨论了如何在自身免疫、感染和癌症中通过治疗靶向Tregs,以重新建立调节反应和效应反应之间的适当平衡。